Toxicological evaluation and antitumoral effect of hR3 monoclonal antibody combined withchemoembolization in metastatic liver treatment.
Phase of Trial: Phase I/II
Latest Information Update: 09 Mar 2017
At a glance
- Drugs Ethiodized oil (Primary) ; Fluorouracil (Primary) ; Nimotuzumab (Primary)
- Indications Advanced breast cancer; Colon cancer; Liver metastases
- Focus Therapeutic Use
- 02 Sep 2011 New trial record